INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Results

77,709 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
RS
Robins Harlan SChief Scientific Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$149K
10.0K sh
Apr 8, 2026
Page 1166 of 1943
← PrevNext →
Apr 10, 2026
traded Apr 8, 2026
+2d
SEC Form 4

Evidence

19
ST
Stevens TonyaChief Financial Officer
NVTSNavitas Semiconductor Corp
Grant or award
A—
559.9K sh
Mar 30, 2026Apr 10, 2026
traded Mar 30, 2026
+11dSEC Form 4

Evidence

19
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
27.7K sh
Apr 7, 2026Apr 10, 2026
traded Apr 7, 2026
+3dSEC Form 4

Evidence

19
SP
Srinivasan PriyaChief People & Purpose Officer
COTYCOTY INC.
Tax withholding
F—
2,347 sh
Apr 4, 2026Apr 10, 2026
traded Apr 4, 2026
+6dSEC Form 4

Evidence

18
BD
Beker DavidEVP, MARKETING
ALSUMISHO AIR LEASE CORP
Disposition to issuer
D$2.37M
36.4K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

18
CH
Clark Yvette HollingsworthDirector
ALSUMISHO AIR LEASE CORP
Disposition to issuer
D$1.64M
25.3K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

18
KK
Korde KishoreEVP
ALSUMISHO AIR LEASE CORP
Disposition to issuer
D$4.09M
62.9K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

18
MS
McCaw SusanDirector
ALSUMISHO AIR LEASE CORP
Disposition to issuer
D$2.01M
30.9K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

18
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.02M
1,756 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

18
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$1.13M
1,956 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

17
MJ
McCallion Kevin J.SVP, Products and Production
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$131K
18.6K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

17
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Grant or award
A—
2,618 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

17
BS
Baugher Joshua ScottChief Financial Officer
AGXARGAN INC
Grant or award
A—
1,670 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

17
GA
Gonzalez Luis ADirector, 10% Owner
AVOMission Produce, Inc.
Grant or award
A—
8,240 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

17
SB
Sarsam Tony BDirector
AVOMission Produce, Inc.
Grant or award
A—
8,240 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,176
1,936 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,244
1,950 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
SR
Savitz RyanEVP, CFO & CBO
DNTHDianthus Therapeutics, Inc. /DE/
Open-market sale · 10b5-1 plan
SELL$739K
8,224 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
1,681 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$283K
12.5K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$1.25M
8,100 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
XZ
Xu ZhenyuChief Scientific Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,800 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$13K
2,786 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
PD
Papadopoulos DidierPresident of Aircraft OEM
JOBYJoby Aviation, Inc.
Open-market sale · 10b5-1 plan
SELL$2,295
271 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
YA
Yeh Kuanling AmyChief Technology Officer
MAXMediaAlpha, Inc.
Open-market sale · 10b5-1 plan
SELL$28K
3,000 sh
Apr 10, 2026Apr 10, 2026
traded Apr 10, 2026
+0dSEC Form 4

Evidence

16
MR
Muken RossPresident
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,239
1,950 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
3,310 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
CJ
Camblong JurgiDirector, Chief Executive Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,800 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
WJ
Walsh Jay JPresident, Franklin Fueling
FELEFRANKLIN ELECTRIC CO INC
Grant or award
A$206K
2,078 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,861 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
VM
Valente ManuelaChief People Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$19K
3,824 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
VT
Vo Thomas T.Director, Chief Executive Officer
NUTXNutex Health Inc.
Other acquisition or disposition
J—
184.1K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,152
1,931 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$1,978
162 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
CC
Collier CharlesPresident, Roku Media
ROKUROKU, INC
Option exercise · 10b5-1 plan
M$8.78M
177.1K sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
SL
Spikes Brent LVP, Global Manufacturing Ops
FELEFRANKLIN ELECTRIC CO INC
Tax withholding
F$54K
548 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
VD
Van Well DaanChief Legal Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$9,424
1,988 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence

16
MP
Menu PhilippeChief Medical Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$14K
2,800 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

16
CG
Cardoza GeorgeChief Financial Officer
SOPHSOPHiA GENETICS SA
Open-market sale · 10b5-1 plan
SELL$6,801
1,403 sh
Apr 8, 2026Apr 10, 2026
traded Apr 8, 2026
+2dSEC Form 4

Evidence

15
EJ
Edgemond JamesCFO AND TREASURER
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$934K
1,617 sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC Form 4

Evidence